$MTCR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Metacrine, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Metacrine, Inc.. Get notifications about new insider transactions in Metacrine, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 25 2021 | MTCR | Metacrine, Inc. | Evans Ronald M | Director | Option Exercise | A | 4.07 | 16,500 | 67,155 | 16,500 | |
| May 25 2021 | MTCR | Metacrine, Inc. | McHutchison John G | Director | Option Exercise | A | 4.07 | 16,500 | 67,155 | 16,500 | |
| May 07 2021 | MTCR | Metacrine, Inc. | Lee Catherine Chai-zon | EVP, Gen. Counsel & ... | Grant | A | 0.00 | 3,846 | 0 | 3,846 | 0 to 3.8 K |
| May 07 2021 | MTCR | Metacrine, Inc. | Millican Trisha | Chief Financial Off ... | Grant | A | 0.00 | 759 | 0 | 41,792 | 41 K to 41.8 K (+1.85 %) |
| Apr 05 2021 | MTCR | Metacrine, Inc. | Owens Julia C. | Director | Option Exercise | A | 5.73 | 33,000 | 189,090 | 33,000 | |
| Mar 18 2021 | MTCR | Metacrine, Inc. | JONKER JEFFREY DAVID | Director | Option Exercise | A | 8.04 | 33,000 | 265,320 | 33,000 | |
| Feb 12 2021 | MTCR | Metacrine, Inc. | Klassen Preston | President & CEO | Option Exercise | A | 10.09 | 247,500 | 2,497,275 | 247,500 | |
| Feb 12 2021 | MTCR | Metacrine, Inc. | Chen Hubert C | Chief Medical Offic ... | Option Exercise | A | 10.09 | 90,000 | 908,100 | 90,000 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Walker Paul Edward | 10% Owner | Option Exercise | C | 0.00 | 332,964 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Walker Paul Edward | 10% Owner | Option Exercise | C | 0.00 | 1,958,333 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Walker Paul Edward | 10% Owner | Buy | P | 13.00 | 769,230 | 9,999,990 | 3,060,527 | 2.3 M to 3.1 M (+33.57 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Walker Paul Edward | 10% Owner | Buy | C | 0.00 | 332,964 | 0 | 2,291,297 | 2 M to 2.3 M (+17.00 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Walker Paul Edward | 10% Owner | Buy | C | 0.00 | 1,958,333 | 0 | 1,958,333 | 0 to 2 M |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Sonsini Peter W. | 10% Owner | Option Exercise | C | 0.00 | 332,964 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Sonsini Peter W. | 10% Owner | Option Exercise | C | 0.00 | 1,958,333 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Sonsini Peter W. | 10% Owner | Buy | P | 13.00 | 769,230 | 9,999,990 | 3,060,527 | 2.3 M to 3.1 M (+33.57 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Sonsini Peter W. | 10% Owner | Buy | C | 0.00 | 332,964 | 0 | 2,291,297 | 2 M to 2.3 M (+17.00 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Sonsini Peter W. | 10% Owner | Buy | C | 0.00 | 1,958,333 | 0 | 1,958,333 | 0 to 2 M |
| Sep 22 2020 | MTCR | Metacrine, Inc. | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 332,964 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 1,958,333 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 13.00 | 769,230 | 9,999,990 | 3,060,527 | 2.3 M to 3.1 M (+33.57 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 332,964 | 0 | 2,291,297 | 2 M to 2.3 M (+17.00 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 1,958,333 | 0 | 1,958,333 | 0 to 2 M |
| Sep 22 2020 | MTCR | Metacrine, Inc. | MAKOWER JOSHUA | 10% Owner | Option Exercise | C | 0.00 | 332,964 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | MAKOWER JOSHUA | 10% Owner | Option Exercise | C | 0.00 | 1,958,333 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | MAKOWER JOSHUA | 10% Owner | Buy | P | 13.00 | 769,230 | 9,999,990 | 3,060,527 | 2.3 M to 3.1 M (+33.57 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | MAKOWER JOSHUA | 10% Owner | Buy | C | 0.00 | 332,964 | 0 | 2,291,297 | 2 M to 2.3 M (+17.00 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | MAKOWER JOSHUA | 10% Owner | Buy | C | 0.00 | 1,958,333 | 0 | 1,958,333 | 0 to 2 M |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Makhzoumi Mohamad | 10% Owner | Option Exercise | C | 0.00 | 332,964 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Makhzoumi Mohamad | 10% Owner | Option Exercise | C | 0.00 | 1,958,333 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Makhzoumi Mohamad | 10% Owner | Buy | P | 13.00 | 769,230 | 9,999,990 | 3,060,527 | 2.3 M to 3.1 M (+33.57 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Makhzoumi Mohamad | 10% Owner | Buy | C | 0.00 | 332,964 | 0 | 2,291,297 | 2 M to 2.3 M (+17.00 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Makhzoumi Mohamad | 10% Owner | Buy | C | 0.00 | 1,958,333 | 0 | 1,958,333 | 0 to 2 M |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Florence Anthony A. Jr. | 10% Owner | Option Exercise | C | 0.00 | 332,964 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Florence Anthony A. Jr. | 10% Owner | Option Exercise | C | 0.00 | 1,958,333 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Florence Anthony A. Jr. | 10% Owner | Buy | P | 13.00 | 769,230 | 9,999,990 | 3,060,527 | 2.3 M to 3.1 M (+33.57 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Florence Anthony A. Jr. | 10% Owner | Buy | C | 0.00 | 332,964 | 0 | 2,291,297 | 2 M to 2.3 M (+17.00 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Florence Anthony A. Jr. | 10% Owner | Buy | C | 0.00 | 1,958,333 | 0 | 1,958,333 | 0 to 2 M |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Chang Carmen | 10% Owner | Option Exercise | C | 0.00 | 332,964 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Chang Carmen | 10% Owner | Option Exercise | C | 0.00 | 1,958,333 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Chang Carmen | 10% Owner | Buy | P | 13.00 | 769,230 | 9,999,990 | 3,060,527 | 2.3 M to 3.1 M (+33.57 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Chang Carmen | 10% Owner | Buy | C | 0.00 | 332,964 | 0 | 2,291,297 | 2 M to 2.3 M (+17.00 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Chang Carmen | 10% Owner | Buy | C | 0.00 | 1,958,333 | 0 | 1,958,333 | 0 to 2 M |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Behbahani Ali | 10% Owner | Option Exercise | C | 0.00 | 332,964 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Behbahani Ali | 10% Owner | Option Exercise | C | 0.00 | 1,958,333 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Behbahani Ali | 10% Owner | Buy | P | 13.00 | 769,230 | 9,999,990 | 3,060,527 | 2.3 M to 3.1 M (+33.57 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Behbahani Ali | 10% Owner | Buy | C | 0.00 | 332,964 | 0 | 2,291,297 | 2 M to 2.3 M (+17.00 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Behbahani Ali | 10% Owner | Buy | C | 0.00 | 1,958,333 | 0 | 1,958,333 | 0 to 2 M |
| Sep 22 2020 | MTCR | Metacrine, Inc. | BASKETT FOREST | 10% Owner | Option Exercise | C | 0.00 | 332,964 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | BASKETT FOREST | 10% Owner | Option Exercise | C | 0.00 | 1,958,333 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | BASKETT FOREST | 10% Owner | Buy | P | 13.00 | 769,230 | 9,999,990 | 3,060,527 | 2.3 M to 3.1 M (+33.57 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | BASKETT FOREST | 10% Owner | Buy | C | 0.00 | 332,964 | 0 | 2,291,297 | 2 M to 2.3 M (+17.00 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | BASKETT FOREST | 10% Owner | Buy | C | 0.00 | 1,958,333 | 0 | 1,958,333 | 0 to 2 M |
| Sep 22 2020 | MTCR | Metacrine, Inc. | New Enterprise Associates 16, ... | 10% Owner | Option Exercise | C | 0.00 | 332,964 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | New Enterprise Associates 16, ... | 10% Owner | Option Exercise | C | 0.00 | 1,958,333 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | New Enterprise Associates 16, ... | 10% Owner | Buy | P | 13.00 | 769,230 | 9,999,990 | 3,060,527 | 2.3 M to 3.1 M (+33.57 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | New Enterprise Associates 16, ... | 10% Owner | Buy | C | 0.00 | 332,964 | 0 | 2,291,297 | 2 M to 2.3 M (+17.00 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | New Enterprise Associates 16, ... | 10% Owner | Buy | C | 0.00 | 1,958,333 | 0 | 1,958,333 | 0 to 2 M |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Adelman Robert J | Option Exercise | C | 0.00 | 396,089 | 0 | 0 | ||
| Sep 22 2020 | MTCR | Metacrine, Inc. | Adelman Robert J | Option Exercise | C | 0.00 | 472,250 | 0 | 0 | ||
| Sep 22 2020 | MTCR | Metacrine, Inc. | Adelman Robert J | Option Exercise | C | 0.00 | 1,960,784 | 0 | 0 | ||
| Sep 22 2020 | MTCR | Metacrine, Inc. | Adelman Robert J | Buy | C | 0.00 | 2,829,123 | 0 | 3,059,123 | 230 K to 3.1 M (+1,230.05 %) | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Adelman Robert J | Buy | P | 13.00 | 230,000 | 2,990,000 | 230,000 | 0 to 230 K | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | venBio Global Strategic Fund, ... | Option Exercise | C | 0.00 | 396,089 | 0 | 0 | ||
| Sep 22 2020 | MTCR | Metacrine, Inc. | venBio Global Strategic Fund, ... | Option Exercise | C | 0.00 | 472,250 | 0 | 0 | ||
| Sep 22 2020 | MTCR | Metacrine, Inc. | venBio Global Strategic Fund, ... | Option Exercise | C | 0.00 | 1,960,784 | 0 | 0 | ||
| Sep 22 2020 | MTCR | Metacrine, Inc. | venBio Global Strategic Fund, ... | Buy | C | 0.00 | 2,829,123 | 0 | 3,059,123 | 230 K to 3.1 M (+1,230.05 %) | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | venBio Global Strategic Fund, ... | Buy | P | 13.00 | 230,000 | 2,990,000 | 230,000 | 0 to 230 K | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Polaris Management Co. VII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 15,118 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Polaris Management Co. VII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 216,106 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Polaris Management Co. VII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 20,585 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Polaris Management Co. VII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 451,666 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Polaris Management Co. VII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 128,201 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Polaris Management Co. VII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,832,582 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Polaris Management Co. VII, L. ... | 10% Owner | Buy | C | 0.00 | 15,118 | 0 | 178,942 | 163.8 K to 178.9 K (+9.23 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Polaris Management Co. VII, L. ... | 10% Owner | Buy | C | 0.00 | 216,106 | 0 | 2,715,316 | 2.5 M to 2.7 M (+8.65 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Polaris Management Co. VII, L. ... | 10% Owner | Buy | C | 0.00 | 20,585 | 0 | 163,824 | 143.2 K to 163.8 K (+14.37 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Polaris Management Co. VII, L. ... | 10% Owner | Buy | C | 0.00 | 451,666 | 0 | 2,499,210 | 2 M to 2.5 M (+22.06 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Polaris Management Co. VII, L. ... | 10% Owner | Buy | C | 0.00 | 128,201 | 0 | 143,239 | 15 K to 143.2 K (+852.51 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Polaris Management Co. VII, L. ... | 10% Owner | Buy | C | 0.00 | 1,832,582 | 0 | 2,047,544 | 215 K to 2 M (+852.51 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Polaris Management Co. VII, L. ... | 10% Owner | Buy | P | 13.00 | 15,038 | 195,494 | 15,038 | 0 to 15 K |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Polaris Management Co. VII, L. ... | 10% Owner | Buy | P | 13.00 | 214,962 | 2,794,506 | 214,962 | 0 to 215 K |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | C | 0.00 | 15,118 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | C | 0.00 | 216,106 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | C | 0.00 | 20,585 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | C | 0.00 | 451,666 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | C | 0.00 | 128,201 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | C | 0.00 | 1,832,582 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | C | 0.00 | 15,118 | 0 | 178,942 | 163.8 K to 178.9 K (+9.23 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | C | 0.00 | 216,106 | 0 | 2,715,316 | 2.5 M to 2.7 M (+8.65 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | C | 0.00 | 20,585 | 0 | 163,824 | 143.2 K to 163.8 K (+14.37 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | C | 0.00 | 451,666 | 0 | 2,499,210 | 2 M to 2.5 M (+22.06 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | C | 0.00 | 128,201 | 0 | 143,239 | 15 K to 143.2 K (+852.51 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | C | 0.00 | 1,832,582 | 0 | 2,047,544 | 215 K to 2 M (+852.51 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | P | 13.00 | 15,038 | 195,494 | 15,038 | 0 to 15 K |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | P | 13.00 | 214,962 | 2,794,506 | 214,962 | 0 to 215 K |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Evans Ronald M | Director | Option Exercise | C | 0.00 | 9,803 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Evans Ronald M | Director | Buy | C | 0.00 | 9,803 | 0 | 9,803 | 0 to 9.8 K |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Millican Trisha | Chief Financial Off ... | Option Exercise | C | 0.00 | 9,803 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Millican Trisha | Chief Financial Off ... | Buy | C | 0.00 | 9,803 | 0 | 67,248 | 57.4 K to 67.2 K (+17.07 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Burow Kristina | Director | Option Exercise | C | 0.00 | 138,734 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Burow Kristina | Director | Option Exercise | C | 0.00 | 138,734 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Burow Kristina | Director | Option Exercise | C | 0.00 | 472,251 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Burow Kristina | Director | Option Exercise | C | 0.00 | 1,960,784 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Burow Kristina | Director | Buy | P | 13.00 | 20,000 | 260,000 | 158,734 | 138.7 K to 158.7 K (+14.42 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Burow Kristina | Director | Buy | C | 0.00 | 138,734 | 0 | 138,734 | 0 to 138.7 K |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Burow Kristina | Director | Buy | P | 13.00 | 210,000 | 2,730,000 | 2,781,769 | 2.6 M to 2.8 M (+8.17 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Burow Kristina | Director | Buy | C | 0.00 | 138,734 | 0 | 2,571,769 | 2.4 M to 2.6 M (+5.70 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Burow Kristina | Director | Buy | C | 0.00 | 472,251 | 0 | 2,433,035 | 2 M to 2.4 M (+24.08 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Burow Kristina | Director | Buy | C | 0.00 | 1,960,784 | 0 | 1,960,784 | 0 to 2 M |
| Sep 22 2020 | MTCR | Metacrine, Inc. | ARCH Venture Fund VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 138,734 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | ARCH Venture Fund VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 138,734 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | ARCH Venture Fund VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 472,251 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | ARCH Venture Fund VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,960,784 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | ARCH Venture Fund VIII, L.P. | 10% Owner | Buy | P | 13.00 | 20,000 | 260,000 | 158,734 | 138.7 K to 158.7 K (+14.42 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | ARCH Venture Fund VIII, L.P. | 10% Owner | Buy | C | 0.00 | 138,734 | 0 | 138,734 | 0 to 138.7 K |
| Sep 22 2020 | MTCR | Metacrine, Inc. | ARCH Venture Fund VIII, L.P. | 10% Owner | Buy | P | 13.00 | 210,000 | 2,730,000 | 2,781,769 | 2.6 M to 2.8 M (+8.17 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | ARCH Venture Fund VIII, L.P. | 10% Owner | Buy | C | 0.00 | 138,734 | 0 | 2,571,769 | 2.4 M to 2.6 M (+5.70 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | ARCH Venture Fund VIII, L.P. | 10% Owner | Buy | C | 0.00 | 472,251 | 0 | 2,433,035 | 2 M to 2.4 M (+24.08 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | ARCH Venture Fund VIII, L.P. | 10% Owner | Buy | C | 0.00 | 1,960,784 | 0 | 1,960,784 | 0 to 2 M |
| Sep 18 2020 | MTCR | Metacrine, Inc. | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 762,961 | 0 | 0 | |
| Sep 18 2020 | MTCR | Metacrine, Inc. | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 1,107,899 | 0 | 0 | |
| Sep 18 2020 | MTCR | Metacrine, Inc. | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 4,599,997 | 0 | 0 | |
| Sep 18 2020 | MTCR | Metacrine, Inc. | Alexandria Venture Investments ... | 10% Owner | Buy | P | 13.00 | 38,461 | 499,993 | 1,307,256 | 1.3 M to 1.3 M (+3.03 %) |
| Sep 18 2020 | MTCR | Metacrine, Inc. | Alexandria Venture Investments ... | 10% Owner | Buy | C | 0.00 | 1,268,795 | 0 | 1,268,795 | 0 to 1.3 M |
| Sep 18 2020 | MTCR | Metacrine, Inc. | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 762,961 | 0 | 0 | |
| Sep 18 2020 | MTCR | Metacrine, Inc. | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 1,107,899 | 0 | 0 | |
| Sep 18 2020 | MTCR | Metacrine, Inc. | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 4,599,997 | 0 | 0 | |
| Sep 18 2020 | MTCR | Metacrine, Inc. | Alexandria Venture Investments ... | 10% Owner | Buy | P | 13.00 | 38,461 | 499,993 | 1,307,256 | 1.3 M to 1.3 M (+3.03 %) |
| Sep 18 2020 | MTCR | Metacrine, Inc. | Alexandria Venture Investments ... | 10% Owner | Buy | C | 0.00 | 1,268,795 | 0 | 1,268,795 | 0 to 1.3 M |
Page: 1